RxDoctor Payments Data

Clay Mattson

Optometrist · Nicholasville, KYNPI 1134132517

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $58,142 of the $92,844 with a category attached, or 62.6%. Alcon accounts for 80.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $35,255 and has fallen 99.6% since, to $128 in 2025. Among optometrist clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$92,844in general payments, 2019–2025

Across 187 payments — averaging $496.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$75K
  • Carl Zeiss Meditec, Inc.$13K
  • Alcon Research LLC$4K
  • Sun Pharmaceutical Industries Inc.$481
  • Glaukos Corporation$347
  • Novartis$118
  • plus $91 from 2 others

What the payments were for

  • Consulting fees$58,14263%
  • Speaking & faculty fees$9,21510%
  • Travel & lodging$18,92220%
  • Food & beverage$6,4407%
  • Education$1250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$92,844 in reported general payments places this provider in the 95th percentile of 712 optometrist providers in Kentucky.

See all optometrist providers in Kentucky

Medicare billing

Part B allowed, 2024
$41,889
Medicare patients
209
Services billed
3,490

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine12$14,777
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol13$928
Latanoprost119$877
Timolol Maleate34$370
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha13$128

Paid to pharmacies, not to this prescriber.

Other optometrist in Nicholasville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →